Highbridge Capital Management LLC purchased a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 150,000 shares of the company’s stock, valued at approximately $2,766,000.
Other institutional investors have also made changes to their positions in the company. Tuttle Capital Management LLC acquired a new stake in Translational Development Acquisition in the 4th quarter valued at about $461,000. Calamos Advisors LLC bought a new stake in shares of Translational Development Acquisition during the fourth quarter valued at approximately $6,915,000. Wolverine Asset Management LLC acquired a new stake in shares of Translational Development Acquisition in the fourth quarter valued at approximately $5,716,000. MMCAP International Inc. SPC bought a new position in Translational Development Acquisition in the 4th quarter worth approximately $6,454,000. Finally, Wealthspring Capital LLC acquired a new position in Translational Development Acquisition during the 4th quarter worth $1,095,000.
Translational Development Acquisition Stock Performance
Shares of TDACU opened at $10.19 on Friday. The company has a fifty day moving average price of $10.10. Translational Development Acquisition Corp. has a 52 week low of $10.00 and a 52 week high of $10.30.
Translational Development Acquisition Profile
Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.
See Also
- Five stocks we like better than Translational Development Acquisition
- How to trade penny stocks: A step-by-step guide
- Target Drops to COVID Lows: Buy the Dip or Cut Losses?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- Which Wall Street Analysts are the Most Accurate?
- Top 3 Beverage Stocks Pouring Out Profits
Want to see what other hedge funds are holding TDACU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Translational Development Acquisition Corp. (NASDAQ:TDACU – Free Report).
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.